How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use?

Source link :

At 12 months, 36.5% of people had discontinued their GLP-1 receptor agonist in a study of nearly 200,000 adults with obesity with or without type 2 diabetes. (JAMA Network Open) In a phase Ib trial, a once-weekly injection of the dual GLP-1/GIP receptor agonist CT-388 led to a mean placebo-adjusted weight loss of 18.8% over […]

Author : News Health

Publish date : 2024-05-28 14:39:56

Copyright for syndicated content belongs to the linked Source.